District of Columbia at a glance
| Adults with obesity (CDC) | Not reported with the states |
|---|---|
| Medicaid pays for GLP-1s for obesity | Not in our KFF extract — ask DC Medicaid |
| Medicare GLP-1 Bridge | $50 copay for eligible Part D members, Jul 1, 2026 – Dec 31, 2027 |
| Physician licensing | District of Columbia Board of Medicine |
| Pharmacy licensing | District of Columbia Board of Pharmacy |
| Main metro areas | Washington, D.C. |
In short, the CDC state obesity maps used on this page do not rank the District of Columbia alongside the states. We did not find the District in the KFF January 2026 state list we use, so ask your DC Medicaid plan directly whether it pays for Wegovy or Zepbound prescribed for obesity.
Insurance and public coverage in District of Columbia
Medicaid. We did not find the District in the KFF January 2026 state list we use, so ask your DC Medicaid plan directly whether it pays for Wegovy or Zepbound prescribed for obesity.
Medicare. Medicare still cannot pay for drugs used only for weight loss under Part D, but the Medicare GLP-1 Bridge is a separate CMS program: from July 1, 2026 to December 31, 2027, eligible Part D members in District of Columbia pay $50 a month for Wegovy (pen or pill), Foundayo or the Zepbound KwikPen after prior authorization. The BALANCE model’s Part D arm will not start in 2027. Open enrollment runs October 15 to December 7, 2026.
Self-pay prices for District of Columbia residents
None of the programs we track charges District of Columbia a different price. These figures were read on the sellers’ own pages:
| Program | Product | Self-pay price | Read (2026) |
|---|---|---|---|
| NexLife (our #1) | Compounded semaglutide | $119/mo on a 12-month plan charged monthly; $139 month to month; no membership | Oct 14 |
| Collective | Compounded semaglutide | $59/mo plus a $199 yearly membership (about $76/mo) | Oct 14 |
| Wegovy pill (NovoCare) | Brand, FDA-approved | $149, $199 or $299 a month by dose | Oct 14 |
| Wegovy pen (NovoCare) | Brand, FDA-approved | $349 a month ($199 for the first two fills for new patients through Dec 31, 2026) | Oct 14 |
Every program with its billing basis and read date is on the compounded GLP-1 price comparison; the cheapest options are on cheapest compounded semaglutide online.
Checking the prescriber and pharmacy
A telehealth clinician who prescribes to you in District of Columbia needs a license District of Columbia recognizes. Physicians answer to the District of Columbia Board of Medicine; you can also search any physician on DocInfo.org. The pharmacy named on your vial label should be licensed by, or hold a nonresident permit from, the District of Columbia Board of Pharmacy. Our pharmacy profiles summarise FDA records for common compounders, and the 503A vs 503B guide explains the two license types.
Shipments go by mail across District of Columbia, including the Washington, D.C..
Questions people in District of Columbia ask
Does Medicaid in District of Columbia pay for Wegovy for weight loss?
We did not find the District in the KFF January 2026 state list we use, so ask your DC Medicaid plan directly whether it pays for Wegovy or Zepbound prescribed for obesity. Wegovy prescribed to lower heart risk is handled under different rules.
Can someone on Medicare in District of Columbia get Wegovy for $50 a month?
Possibly. Since July 1, 2026, the Medicare GLP-1 Bridge has let eligible Part D members anywhere in the U.S., including District of Columbia, fill Wegovy, Foundayo or the Zepbound KwikPen for a $50 monthly copay. It runs through December 31, 2027, uses BMI-based criteria and needs prior authorization; open enrollment runs October 15 to December 7, 2026.
What does semaglutide cost in District of Columbia without insurance?
Prices are national, so District of Columbia pays the same as other states. On October 14, 2026: compounded semaglutide $119 a month at NexLife on a 12-month plan charged monthly, or $59 plus a $199 yearly membership at Collective; brand Wegovy $149–$299 (pill) or $349 (pen) through NovoCare.
How can I check that an online prescriber is licensed in District of Columbia?
Look the clinician up on the District of Columbia Board of Medicine website or on DocInfo.org. Nurse practitioners in District of Columbia are licensed separately, usually by the board of nursing.
Is compounded semaglutide allowed in District of Columbia?
Yes, within federal limits. A pharmacy licensed by, or permitted to ship into, District of Columbia may compound it for you on an individual prescription, but compounded semaglutide is not FDA-approved and FDA has warned sellers who market copies or salt forms. Check the pharmacy with the District of Columbia Board of Pharmacy.
Neighbouring states
Maryland, Virginia. See all state guides, the provider comparison or our NexLife review.
Sources
Informational only, not medical advice. Compounded semaglutide is not FDA-approved and is not the same product as Wegovy® or Ozempic® (trademarks of Novo Nordisk).